<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Canada Finance: HBP.TO News</title><copyright>Copyright (c) 2013 Yahoo! Inc. All rights reserved.</copyright><link>http://ca.finance.yahoo.com/q/h?s=hbp.to</link><description>Latest Financial News for HELIX BIOPHARM</description><language>en-CA</language><lastBuildDate>Mon, 08 Apr 2013 12:11:42 GMT</lastBuildDate><image><url>http://l.yimg.com/a/i/brand/purplelogo/uh/us/fin.gif</url><title>Yahoo! Canada Finance: HBP.TO News</title><link>http://ca.finance.yahoo.com/q/h?s=hbp.to</link><width>144</width><height>45</height></image><item><title>Helix BioPharma Corp. Announces L-DOS47 Scientific Poster to Be Presented at American Association for Cancer Research Annual Meeting in Washington, DC</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/helix-biopharma-corp-announces-l-121142413.html</link><description></description><guid isPermaLink="false">yahoo_finance/1206322705</guid><pubDate>Mon, 08 Apr 2013 12:11:42 GMT</pubDate></item><item><title>Helix Biopharma Corp. Initiates Enrollment for Third Cohort and Expansion of Centres in Polish Phase I/II Clinical Study of Its Lung Cancer Drug Candidate L-DOS47</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/helix-biopharma-corp-initiates-enrollment-201035555.html</link><description></description><guid isPermaLink="false">yahoo_finance/57738904</guid><pubDate>Thu, 04 Apr 2013 20:10:35 GMT</pubDate></item><item><title>Helix BioPharma Corp. Announces L-DOS47 Scientific Presentation to Be Made at BIT LifeScience&apos;s 5th International Congress of Antibodies</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/helix-biopharma-corp-announces-l-224046668.html</link><description></description><guid isPermaLink="false">yahoo_finance/2194785698</guid><pubDate>Mon, 18 Mar 2013 22:40:46 GMT</pubDate></item><item><title>Helix BioPharma Corp. Announces Q2 Fiscal 2013 Results</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/helix-biopharma-corp-announces-q2-223006358.html</link><description></description><guid isPermaLink="false">yahoo_finance/700652212</guid><pubDate>Mon, 11 Mar 2013 22:30:06 GMT</pubDate></item><item><title>Helix BioPharma Corp. Announces Extension of 2009 Warrant Expiry Date</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/helix-biopharma-corp-announces-extension-220500035.html</link><description></description><guid isPermaLink="false">yahoo_finance/3469662576</guid><pubDate>Thu, 07 Mar 2013 22:05:00 GMT</pubDate></item><item><title>Helix BioPharma Announces Director Resignation</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/helix-biopharma-announces-director-resignation-143054913.html</link><description></description><guid isPermaLink="false">yahoo_finance/269296621</guid><pubDate>Mon, 25 Feb 2013 14:30:54 GMT</pubDate></item><item><title>Helix BioPharma Corp. Announces Extension of 2009 Warrant Expiry Date</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/helix-biopharma-corp-announces-extension-190845142.html</link><description></description><guid isPermaLink="false">yahoo_finance/1003194107</guid><pubDate>Thu, 21 Feb 2013 19:08:45 GMT</pubDate></item><item><title>Helix BioPharma Announces Appointment of Director</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/helix-biopharma-announces-appointment-director-190355830.html</link><description></description><guid isPermaLink="false">yahoo_finance/1055553115</guid><pubDate>Thu, 21 Feb 2013 19:03:55 GMT</pubDate></item><item><title>Helix BioPharma Announces Director Resignation</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/helix-biopharma-announces-director-resignation-160111547.html</link><description></description><guid isPermaLink="false">yahoo_finance/87037783</guid><pubDate>Sun, 10 Feb 2013 16:01:11 GMT</pubDate></item><item><title>Helix Announces Completion of the Sale of Its Rivex Pharma Division to Pharmascience</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/helix-announces-completion-sale-rivex-175913149.html</link><description></description><guid isPermaLink="false">yahoo_finance/2245267090</guid><pubDate>Fri, 25 Jan 2013 17:59:13 GMT</pubDate></item><item><title>Helix Announces Shareholder Approval for the Sale of Its Rivex Pharma Division to Pharmascience and Other Results of Its Annual General and Special Meeting</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/helix-announces-shareholder-approval-sale-231213252.html</link><description></description><guid isPermaLink="false">yahoo_finance/661413863</guid><pubDate>Thu, 24 Jan 2013 23:12:13 GMT</pubDate></item><item><title>Helix BioPharma Announces Appointment of Director</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/helix-biopharma-announces-appointment-director-030928918.html</link><description></description><guid isPermaLink="false">yahoo_finance/1960909057</guid><pubDate>Fri, 21 Dec 2012 03:09:28 GMT</pubDate></item><item><title>Clinical Update: Helix BioPharma Corp. Completes Enrollment in First Cohort and Initiates Second Cohort in Polish Phase I/II Clinical Study of Its Lung Cancer Drug Candidate L-DOS47</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/clinical-helix-biopharma-corp-completes-183839726.html</link><description></description><guid isPermaLink="false">yahoo_finance/3073836284</guid><pubDate>Thu, 20 Dec 2012 18:38:39 GMT</pubDate></item><item><title>Helix BioPharma Announces Director Resignations</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/helix-biopharma-announces-director-resignations-153542428.html</link><description></description><guid isPermaLink="false">yahoo_finance/2023220502</guid><pubDate>Mon, 17 Dec 2012 15:35:42 GMT</pubDate></item><item><title>Helix BioPharma Announces Director Resignations</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/helix-biopharma-announces-director-resignations-150700708.html</link><description></description><guid isPermaLink="false">yahoo_finance/489823280</guid><pubDate>Mon, 17 Dec 2012 15:07:00 GMT</pubDate></item><item><title>Helix BioPharma and Merck Terminate Material Transfer and License Option Agreement for Topical Interferon Alpha-2b Development Program</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/helix-biopharma-merck-terminate-material-220100084.html</link><description></description><guid isPermaLink="false">yahoo_finance/2295166447</guid><pubDate>Fri, 14 Dec 2012 22:01:00 GMT</pubDate></item><item><title>Helix BioPharma Corp. Announces Fiscal 2013 Q1 Results</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/helix-biopharma-corp-announces-fiscal-233827676.html</link><description></description><guid isPermaLink="false">yahoo_finance/3947982796</guid><pubDate>Wed, 12 Dec 2012 23:38:27 GMT</pubDate></item><item><title>Helix BioPharma Corp. Announces Sale of Rivex Pharma Division to Pharmascience Inc.</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/helix-biopharma-corp-announces-sale-124606536.html</link><description></description><guid isPermaLink="false">yahoo_finance/379075940</guid><pubDate>Mon, 10 Dec 2012 12:46:06 GMT</pubDate></item><item><title>Helix BioPharma Corp. Announces Fiscal 2012 Results</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/helix-biopharma-corp-announces-fiscal-210500208.html</link><description></description><guid isPermaLink="false">yahoo_finance/515562510</guid><pubDate>Thu, 25 Oct 2012 21:05:00 GMT</pubDate></item><item><title>Helix BioPharma Corp. Announces First Patient Enrolled and First Dose Administered in Polish Phase I/II Clinical Study of Its Lung Cancer Drug Candidate L-DOS47</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/helix-biopharma-corp-announces-first-210500090.html</link><description></description><guid isPermaLink="false">yahoo_finance/2183986633</guid><pubDate>Tue, 23 Oct 2012 21:05:00 GMT</pubDate></item></channel></rss>